Designing scaffolds to enhance transplanted myoblast survival and migration

Tissue Engineering

Volumn 12, Issue 5, 2006, Pages 1295-1304

  Hill, Elliott ^a   Boontheekul, Tanyarut ^a,b   Mooney, David J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL ENGINEERING; CELLS; COMPOSITION; GELS; GROWTH KINETICS; MUSCLE;

MUSCLE REGENERATION; MYOBLAST TRANSPLANTATION; PEPTIDE-MODIFIED ALGINATE GELS; SCAFFOLD COMPOSITION;

TRANSPLANTATION (SURGICAL);

ALGINIC ACID; CELL ADHESION MOLECULE; FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; GEL; HINDLIMB; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN SECRETION;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL MOVEMENT; CELL SURVIVAL; FIBROBLAST GROWTH FACTOR 2; GELS; GLUCURONIC ACID; HEPATOCYTE GROWTH FACTOR; HEXURONIC ACIDS; HUMANS; MICE; MUSCLE, SKELETAL; MYOBLASTS, SKELETAL; OLIGOPEPTIDES; REGENERATION; TISSUE ENGINEERING;

EID: 33745770464     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.12.1295     Document Type: Article

References (48)

1. WHO. Global burden of musculoskeletal disease revealed in new WHO report. Bull. World Health Org. 81, 853, 2003.
2. Rappelee, D.A., and Werb, Z. Macrophage-derived growth factors. Curr. Top. Microbiol. Immunol. 181, 87, 1992.
3. Straub, V., Rafael, J.A., Chamberlain, J.S., and Campbell, K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375, 1997.
4. Tidball, J.G. Inflammatory cell response to acute muscle injury. Med. Sci. Sports Exerc. 27, 1022, 1995.
5. Hill, M., Wernig, A., and Goldspink, G. Muscle satellite (stem) cell activation during local tissue injury and repair. J. Anat. 203, 89, 2003.
6. Johnson, S.E., and Allen, R.E. Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. Exp. Cell Res. 219, 449, 1995.
7. Miller, K.J., Thaloor, D., Maltesen, S., and Pavlath, G.K. Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am. J. Physiol. Cell Physiol. 278, C174, 2000.
8. Scale, P., Sabourin, L.A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., and Rudnicki, M.A. Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777, 2000.
9. Horsley, V., Jansen, K.M., Mills, S.T., and Pavlath, G.K. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483, 2003.
10. Zammit, P.S., Heslop, L., Hudon, V., Rosenblatt, J.D., Tajbakhsh, S., Buckingham, M.E., Beauchamp, J.R., and Partridge, T. A. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp. Cell Res. 281, 39, 2002.
11. Hanada, E.Y. Efficacy of rehabilitative therapy in regional musculoskeletal conditions. Best Pract. Res. Clin. Rheumatol. 17, 151, 2003.
12. Conboy, I.M., and Rando, T.A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397, 2002.
13. Zammit, P.S., Golding, J.P., Nagata, Y., Hudon, V., Partridge, T.A., and Beauchamp, J.R. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J. Cell Biol. 166, 347, 2004.
14. Leshem, Y., Spicer, D.B., Gal-Levi, R., and Halevy, O. Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27. J. Cell Physiol. 184, 101, 2000.
15. Rubin, J.S., Day, R.M., Breckenridge, D., Atabey, N., Taylor, W.G., Stahl, S.J., Wingfield, P.T., Kaufman, J.D., Schwall, R., and Bottaro, D.P. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling. J. Biol. Chem. 276, 32977, 2001.
16. Tatsumi, R., Anderson, I.E., Nevoret, C.J., Halevy, O., and Allen, R.E. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev. Biol. 194, 114, 1998.
17. Allen, R.E., Dodson, M.V., and Luiten, L.S. Regulation of skeletal muscle satellite cell proliferation by bovine pituitary fibroblast growth factor. Exp. Cell Res. 152, 154, 1984.
18. Cornelison, D.D., and Wold, B.J. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev. Biol. 191, 270, 1997.
19. Cornelison, D.D., Filla, M.S., Stanley, H.M., Rapraeger, A.C., and Olwin, B.B. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev. Biol. 239, 79, 2001.
20. Rapraeger, A.C. Syndecan-regulated receptor signaling. J. Cell Biol. 149, 995, 2000.
21. Pelinkovic, D., Martinek, V., Engelhardt, M., Lee, J.Y., Fu, F., and Huard, J. [Tissue engineering and gene therapy of the musculoskeletal system with muscle cells.] Z. Orthop. Ihre Grenzgeb. 138, 402, 2000.
22. Wright, V.J., Peng, H., and Huard, J. Muscle-based gene therapy and tissue engineering for the musculoskeletal system. Drug Discov. Today 6, 728, 2001.
23. Heslop, L., Beauchamp, J.R., Tajbakhsh, S., Buckingham, M.E., Partridge, T.A., and Zammit, P.S. Transplanted primary neonatal myoblasts can give rise to functional satellite cells as identified using the Myf5nlacZl+ mouse. Gene Ther. 8, 778, 2001.
24. Gussoni, E., Soneoka, Y., Strickland, C.D., Buzney, E.A., Khan, M.K., Flint, A.F., Kunkel, L.M., and Mulligan, R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390, 1999.
25. Saxena, A.K., Marier, J., Benvenuto, M., Willital, G.H., and Vacanti, J.P. Skeletal muscle tissue engineering using isolated myoblasts on synthetic biodegradable polymers: preliminary studies. Tissue Eng. 5, 525, 1999.
26. Skuk, D., Goulet, M. Roy, B., and Tremblay, J.P. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans. Exp. Neurol. 175, 112, 2002.
27. Pouzet, B., Vilquin, J.T., Hagege, A.A., Scorsin, M., Messas, E., Fiszman, M., Schwartz, K., and Menasche, P. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann. Thorac. Surg. 71, 844; discussion 850, 2001.
28. Skuk, D., and Tremblay, J.P. Myoblast transplantation: the current status of a potential therapeutic tool for myopathies. J. Muscle Res. Cell Motil. 24, 285, 2003.
29. Wernig, A., Zweyer, M., and Irintchev, A. Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles. J. Physiol. 522 Pt 2, 333, 2000.
30. Beauchamp, J.R., Morgan, J.E., Pagel, C.N., and Partridge, T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144, 1113, 1999.
31. Qu, Z., Balkir, L., van Deutekom, J.C., Robbins, P.D., Pruchnic, R., and Huard, J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142, 1257, 1998.
32. Alsberg, E., Anderson, K.W., Albeiruti, A., Franceschi, R.T., and Mooney, D.J. Cell-interactive alginate hydrogels for bone tissue engineering. J. Dent. Res. 80, 2025, 2001.
33. Li, A.A., MacDonald, N.C., and Chang, P.L. Effect of growth factors and extracellular matrix materials on the proliferation and differentiation of microencapsulated myoblasts. J. Biomater. Sci. Polym. Ed. 14, 533, 2003.
34. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.
35. Kong, H.J., Kaigler, D., Kim, K., and Mooney, D.J. Controlling rigidity and degradation of alginate hydrogels via molecular weight distribution. Biomacromolecules 5, 1720, 2004.
36. Kong, H.J., Smith, M.K., and Mooney, D.J. Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 24, 4023, 2003.
37. Rowley, J. Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 60, 217, 2002.
38. Chan, C., Burrows, L.L., and Deber, C.M. Helix induction in antimicrobial peptides by alginate in biofilms. J. Biol. Chem. 279, 38749, 2004.
39. Hashimoto, T., Suzuki, Y., Tanihara, M., Kakimaru, Y., and Suzuki, K. Development of alginate wound dressings linked with hybrid peptides derived from laminin and elastin. Biomaterials 25, 1407, 2004.
40. Rowley, J.A., Madlambayan, G., and Mooney, D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45, 1999.
41. Alsberg, E., Anderson, K.W., Albeiruti, A., Rowley, J.A., and Mooney, D.J. Engineering growing tissues. Proc. Natl. Acad. Sci. USA 99, 12025, 2002.
42. Gullberg, D., and Ekblom, P. Extracellular matrix and its receptors during development. Int. J. Dev. Biol. 39, 845, 1995.
43. Eiselt, P., Yeh, J., Latvala, R.K., Shea, L.D., and Mooney, D.J. Porous carriers for biomedical applications based on alginate hydrogels. Biomaterials 21, 1921, 2000.
44. Zeltinger, J., Sherwood, J.K., Graham, D.A., Mueller, R., and Griffith, L.G. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng. 7, 557, 2001.
45. Gospodarowicz, D., Weseman, J., Moran, J.S., and Lindstrom, J. Effect of fibroblast growth factor on the division and fusion of bovine myoblasts. J. Cell Biol. 70, 395, 1976.
46. Sheehan, S.M., and Allen, R.E. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor. J. Cell Physiol. 181, 499, 1999.
47. Lefaucheur, J.P., and Sebille, A. The cellular events of injured muscle regeneration depend on the nature of the injury. Neuromusc. Disord. 5, 501, 1995.
48. Mitchell, C.A., McGeachie, J.K., and Grounds, M.D. The exogenous administration of basic fibroblast growth factor to regenerating skeletal muscle in mice does not enhance the process of regeneration. Growth Factors 13, 37, 1996.